MA04.10 Molecular Characteristics of Non-Small Cell Lung Cancer with MET Fusions von Zaemes, J., Tolulope, A., Elliott, A., Rafeh Naqash, A., Nagasaka, M., Kim, S.Y., Chakra Turaga, R., Oberley, M., Nieva, J., Borghaei, H., Halmos, B., Sledge, G.W., Liu, S.V., Ma, P.C., Kim, C.

Volltext

The impact of immunosuppressive agents on immune checkpoint inhibitor efficacy in patients with advanced melanoma: A real‐world, multicenter, retrospective study von Lev‐Ari, Shaked, Serzan, Michael, Wu, Tianmin, Ip, Andrew, Pascual, Lauren, Sinclaire, Brittany, Adams, Shari, Marafelias, Michael, Ayyagari, Lakshmi, Gill, Sarvarinder K., Ma, Barbara, Zaemes, Jacob P., Della Pia, Alexandra, Alaoui, Adil, Madhavan, Subha, Belouali, Anas, Pecora, Andrew, Ahn, Jaeil, Atkins, Michael B., Shah, Neil J.

Volltext

NF-κB upregulates glutamine-fructose-6-phosphate transaminase 2 to promote migration in non-small cell lung cancer von Szymura, Szymon J, Zaemes, Jacob P, Allison, David F, Clift, Sheena H, D'Innocenzi, Jaclyn M, Gray, Lisa G, McKenna, Brian D, Morris, Benjamin B, Bekiranov, Stefan, LeGallo, Robin D, Jones, David R, Mayo, Marty W

Volltext

EP.13A.03 A Phase II Study of Vobramitamab Duocarmazine in Patients with Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer von Gupta, B., Zaemes, J.P., Yeung, V., Reuss, J., Aggarwal, V., Thompson, J., Swanson, N., de Miguel Perez, D., Ahn, J., Chen, K., Veytsman, I., Gutierrez, M., Rolfo, C.D., Liu, S.V., Kim, C.

Volltext

Associations between psychosocial risk factors and immune checkpoint inhibitor outcomes von Derry-Vick, Heather, Zaemes, Jacob Peter, Ahn, Jaeil, Pascual, Lauren, Sinclaire, Brittany, Lev-Ari, Shaked, Alaoui, Adil, Sridhar, Aishwarya, Adams, David, Della Pia, Alexandra, Pecora, Andrew L, Atkins, Michael B., Ip, Andrew, Shah, Neil J.

Volltext

PET/CT scan and biopsy-driven approach for safe anti-PD-1 therapy discontinuation in patients with advanced melanoma von Gibney, Geoffrey T., Zaemes, Jacob, Shand, Shelly, Shah, Neil J., Swoboda, David, Gardner, Kellie, Radfar, Arash, Petronic-Rosic, Vesna, Reilly, Michael J., Al-Refaie, Waddah B., Rapisuwon, Suthee, Atkins, Michael B.

Volltext

P1.12-08 Characterization of MET Exon 14 Skipping Analog (Y1003) in Non-Small Cell Lung Cancer (NSCLC) von Kim, S.Y., Narvel, H.G., Gandhi, N., Marks, J.A., Zaemes, J.P., Dacic, S., Liu, S.V., Kim, C., Ma, P.C., Reckamp, K., Feldman, R., Nagasaka, M., Khan, H., Uprety, D., Xiu, J., Vanderwalde, A., Cheng, H., Halmos, B.

Volltext

615 The impact of gender including female menopausal status on the safety and efficacy of immune checkpoint inhibitors von Ari, Shaked Lev, Zaemes, Jacob, Ozisik, Deniz, Zemel, Rachel A, Tan, Ming, Pascual, Lauren, Sinclaire, Brittany, Alaoui, Adil, DellaPia, Alexandra, Pecora, Andrew, Atkins, Michael B, Ip, Andrew, Shah, Neil J

Volltext

1317 Enhancing patient safety in melanoma treatment: harnessing machine learning for predicting immune-related adverse events von Zhang, Yili, Ari, Shaked Lev, Gupta, Samir, Zaemes, Jacob, Shah, Neil J, Alaoui, Adil, Madhavan, Subha, McGarvey, Peter, Atkins, Michael B

Volltext

Immune checkpoint inhibitors (ICI) in advanced sarcomatoid renal cell carcinoma (sRCC): A multicenter study von Gopalakrishnan, Dharmesh, Collier, Katharine, Park, Joseph J, Zaemes, Jacob P, Lam, Elaine Tat, Alaklabi, Sabah, Jaeger, Ellen, Parikh, Rahul Atul, Barata, Pedro C., Kauffman, Eric, Atkins, Michael B., Alva, Ajjai Shivaram, Yang, Yuanquan, George, Saby

Volltext

1418 Treatment-free survival in patients with advanced melanoma and non-small cell lung cancer receiving immune checkpoint inhibitors: real-world outcomes over a 3-year timespan von Zaemes, Jacob, Ari, Shaked Lev, Pascual, Lauren, Jegede, Opeyemi A, Arias-Orozco, Natali, Sinclaire, Brittany, DellaPia, Alexandra, Zemel, Rachel A, Zhang, Yili, Gupta, Samir, Alaoui, Adil, Ip, Andrew, Atkins, Michael B, Regan, Meredith, Shah, Neil J

Volltext